Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,170 | 33,500 | 37,452 | 41,042 | 44,527 |
| Receivables | 15 | 9 | 30 | 24 | 15 |
| TOTAL | $29,503 | $33,939 | $38,224 | $42,347 | $46,227 |
| Non-Current Assets | |||||
| Intangibles | 219 | 223 | 227 | 230 | 234 |
| TOTAL | $219 | $223 | $227 | $230 | $234 |
| Total Assets | $29,722 | $34,161 | $38,450 | $42,577 | $46,461 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 995 | 583 | 792 | 463 | 366 |
| Accrued Expenses | 388 | 88 | 182 | 478 | N/A |
| TOTAL | $1,383 | $670 | $974 | $941 | $366 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 34,231 | 34,771 | 27,142 | 31,307 | 278 |
| TOTAL | $34,231 | $34,771 | $27,142 | $31,307 | $278 |
| Total Liabilities | $35,614 | $35,442 | $28,116 | $32,248 | $645 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107 | 104 | 104 | N/A | N/A |
| Common Shares | 65,592 | 65,589 | 65,589 | 65,589 | 55,851 |
| Retained earnings | -78,234 | -73,338 | -61,456 | -60,350 | -27,583 |
| Other shareholders' equity | -139 | -139 | -139 | 5,089 | 17,548 |
| TOTAL | $-5,892 | $-1,281 | $10,334 | $10,329 | $45,816 |
| Total Liabilities And Equity | $29,722 | $34,161 | $38,450 | $42,577 | $46,461 |